Literature DB >> 7843079

Biological markers and occupational lung disease: mineral dust-induced respiratory disorders.

P J Borm1.   

Abstract

There is a need for methods to monitor early adverse effects, exposure, and/or susceptibility of individual subjects due to occupational and environmental causes. This paper discusses the experimental origin, value, and validity of several biological indicators, termed biomarkers, that were used to study coal dust-induced respiratory disorders. The findings are presented in a framework to visualize problems and challenges when developing biomarkers. Taking the framework of mineral dust-induced lung disorders as an example, it is demonstrated how carefully designed follow-up studies are a prerequisite to test the validity and use of events often put forward as biomarkers. It is concluded from the data that serum type III procollagen is neither an exposure nor an (early) effect marker, antioxidant enzyme expression is related to the early inflammatory response after mineral dust inhalation, while the evidence is accumulating that tumor necrosis factor-alpha is a susceptibility marker for progression in mineral dust-induced lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843079     DOI: 10.3109/01902149409064401

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.

Authors:  R P Schins; R J Lamers; B Préat; P J Borm
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

2.  Oxidative DNA damage in peripheral blood lymphocytes of coal workers.

Authors:  R P Schins; P A Schilderman; P J Borm
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

3.  Risk of gastric cancer in pneumoconiotic coal miners and the effect of respiratory impairment.

Authors:  G M Swaen; J M Meijers; J J Slangen
Journal:  Occup Environ Med       Date:  1995-09       Impact factor: 4.402

Review 4.  Serum biomarkers in interstitial lung diseases.

Authors:  Argyris Tzouvelekis; George Kouliatsis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.